How has this study helped patients and
researchers?
This study helped researchers learn more about how durvalumab together with
tremelimumab works in participants with advanced or metastatic NSCLC.
Researchers look at the results of many studies to decide which treatments work
best and are safest. This summary shows only the main results from this one
study. Other studies may provide new information or different results.
Further clinical studies with durvalumab and tremelimumab are planned.
19 | Clinical Study Results